Investing in Innovation, a pan-African initiative to support the commercialization and impact of African health supply chain innovators, is seeking applications for its second cohort.
Selected early and growth-stage start-ups will receive risk-tolerant grant funding and access to market support to accelerate their scale. The program is funded by the Bill & Melinda Gates Foundation, and sponsored by AmerisourceBergen, Merck Sharpe & Dohme (MSD), Microsoft, and Chemonics. Applications are open until June 26. The selected start-ups will be announced on September 14.
AI solutions to improve patient management and diagnosis on the continent gained traction
Guidepost, a South African healthtech start-up, launched an AI-powered chatbot to enable users living with diabetes access care and information to manage their conditions better. The solution will analyze patients’ information and provide personalized care and coaching, as well as connect them to professionals accredited in diabetes education.
Still in South Africa, AstraZeneca is partnering with MedSol AI Solutions to scale an AI solution for rapid detection of breast cancer using a WiFi enabled ultrasound probe. The solution will be deployed in rural clinics across the country to drive early detection and ensure positive health outcomes for patients.
Similarly, AstraZeneca is also partnering with Tricog Health to deploy an AI-powered tool providing rapid electrocardiogram tests in Kenyan markets. The solution, already piloted in India, is aimed at ensuring early diagnosis and treatment of heart diseases.
Both partnerships are part of AstraZeneca’s newly launched Africa Health Innovation Hub to invest in, and mainstream technology solutions to bridge gaps in access to healthcare, particularly in rural and underserved areas.
Read full article – https://www.salientadvisory.com
